EAM Investors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

EAM Investors’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-69,424	Closed	-$1.44M	–	316
2019 Q4	$1.44M	Buy	+69,424	New	+$1.17M	0.32%	154
2017 Q2	–	Sell	-132,595	Closed	-$3.57M	–	387
2017 Q1	$3.57M	Buy	132,595 +95,713	+260%	+$1.95M	0.56%	43
2016 Q4	$701K	Buy	+36,882	New	+$705K	0.09%	288
2015 Q2	–	Sell	-39,120	Closed	-$881K	–	397
2015 Q1	$881K	Buy	+39,120	New	+$906K	0.1%	312

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

EAM Investors's FLXN Position: Q1 2020 in Review

EAM Investors sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 69,424 shares — an estimated $1.44M sold.

EAM Investors first reported a position in FLXN in Q1 2015 and held it in 4 quarters. The position peaked at $3.57M in Q1 2017. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

EAM Investors reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
EAM Investors sold 69,424 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $1.44M.
EAM Investors first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and held it in 4 quarters.
EAM Investors's Flexion Therapeutics, Inc. position peaked at $3.57M in Q1 2017.
123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.